Cresco’s marijuana asset sales could hit $500 million after Columbia Care deal, analysts say
Cresco Labs is expected to sell off $250 million-$500 million worth of marijuana cultivation and retail licenses largely to meet state license limits as part of its planned $2 billion acquisition of rival Columbia Care.